>
Israel First Vs America First Conservatives
The COVID Vaccine DNA Bombshell They Tried to Hide | Exclusive with Dr. David Speicher
Alarm Bells Going off EVERYWHERE, and Putin and China Smell Blood | Redacted w Clayton Morris
Ben Shapiro Joining CNN Exposes His REAL Scheme
Goodbye, Cavities? Scientists Just Found a Way to Regrow Tooth Enamel
Scientists Say They've Figured Out How to Transcribe Your Thoughts From an MRI Scan
SanDisk stuffed 1 TB of storage into the smallest Type-C thumb drive ever
Calling Dr. Grok. Can AI Do Better than Your Primary Physician?
HUGE 32kWh LiFePO4 DIY Battery w/ 628Ah Cells! 90 Minute Build
What Has Bitcoin Become 17 Years After Satoshi Nakamoto Published The Whitepaper?
Japan just injected artificial blood into a human. No blood type needed. No refrigeration.
The 6 Best LLM Tools To Run Models Locally
Testing My First Sodium-Ion Solar Battery
A man once paralyzed from the waist down now stands on his own, not with machines or wires,...

The approval last week is a turnaround for the agency, which had imposed a moratorium in 2013 on disease tests sold by the company, 23andMe, based in Mountain View, Calif. The decision is expected to open the floodgates for more direct-to-consumer tests for disease risks, drawing a road map for other companies to do the same thing.
The company will now be reporting telltale markers for 10 diseases. Most, such as factor XI deficiency, a blood clotting disorder, and Gaucher disease type 1, an organ and tissue illness, and celiac disease are rare. People who buy the $199 Ancestry and Health test from the company will automatically learn if they have mutations increasing their risk for those diseases.
Risk genes for Alzheimer's and Parkinson's are treated separately. Customers will have to specifically say that they want that information. The company's website offers links to genetic counselors for those who are weighing whether to be tested. If they want those results they will be included at no extra charge, although patients have to pay for the counseling separately.